Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Metcalfe

Showing results (261-270 of 302) with videos related to

Pageof 31
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 10, 2006
Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patientsRaju V S R K Gottumukkala, Nikos G Gavalas, Samia Akhtar, et al.
Annals of Surgical Oncology|September 29, 2020
Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational StudyKelly A Metcalfe, Andrea Eisen, Aletta Poll, et al.
Medicine|March 11, 2005
Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) diseaseFabian Chen, Sara L Day, Russell A Metcalfe, et al.
Brain and Cognition|January 16, 2014
Exploring inhibitory deficits in female premutation carriers of fragile X syndrome: through eye movementsAnnie L Shelton, Kim Cornish, Claudine Kraan, et al.
Journal of Medical Genetics|December 20, 2023
Recontact to return new or updated <i>PALB2</i> genetic results in the clinical laboratory settingSeema Panchal, Radhika Mahajan, Navneet Aujla, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growthW M Drake, P V Carroll, K T Maher, et al.
Clinical Genetics|November 26, 2009
Implementation of ironXS: a study of the acceptability and feasibility of genetic screening for hereditary hemochromatosis in high schoolsM B Delatycki, M Wolthuizen, V Collins, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly A Metcalfe, William D Foulkes, Henry T Lynch, et al.
Breast Cancer Research and Treatment|June 19, 2017
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experimentAlexander Liede, Carol A Mansfield, Kelly A Metcalfe, et al.
Gynecologic Oncology|December 14, 2004
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriersKelly A Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Pageof 31

Showing results (261-270 of 302) with videos related to

Sort By:
Pageof 31
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 10, 2006
Function-blocking autoantibodies to the melanin-concentrating hormone receptor in vitiligo patientsRaju V S R K Gottumukkala, Nikos G Gavalas, Samia Akhtar, et al.
Annals of Surgical Oncology|September 29, 2020
Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational StudyKelly A Metcalfe, Andrea Eisen, Aletta Poll, et al.
Medicine|March 11, 2005
Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) diseaseFabian Chen, Sara L Day, Russell A Metcalfe, et al.
Brain and Cognition|January 16, 2014
Exploring inhibitory deficits in female premutation carriers of fragile X syndrome: through eye movementsAnnie L Shelton, Kim Cornish, Claudine Kraan, et al.
Journal of Medical Genetics|December 20, 2023
Recontact to return new or updated <i>PALB2</i> genetic results in the clinical laboratory settingSeema Panchal, Radhika Mahajan, Navneet Aujla, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2003
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growthW M Drake, P V Carroll, K T Maher, et al.
Clinical Genetics|November 26, 2009
Implementation of ironXS: a study of the acceptability and feasibility of genetic screening for hereditary hemochromatosis in high schoolsM B Delatycki, M Wolthuizen, V Collins, et al.
Hereditary Cancer in Clinical Practice|March 13, 2010
Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation CarriersKelly A Metcalfe, William D Foulkes, Henry T Lynch, et al.
Breast Cancer Research and Treatment|June 19, 2017
Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experimentAlexander Liede, Carol A Mansfield, Kelly A Metcalfe, et al.
Gynecologic Oncology|December 14, 2004
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriersKelly A Metcalfe, Henry T Lynch, Parviz Ghadirian, et al.
Pageof 31